Senior Director
Novo Nordisk
Jill Lee is Senior Director of Regulatory Policy & Intelligence at Novo Nordisk. Jill is the US policy lead for digital health, medical devices, combination products and patient focused drug development. Jill has over 15 years of industry experience and began her career providing regulatory legal support for medical devices and pharmaceuticals. Jill holds a JD from Rutgers University and a BA from Mary Washington University.
Disclosure information not submitted.
FDA Expectations for using Digital Tools in Decentralized Clinical Trials
Wednesday, October 4, 2023
2:00 PM – 3:00 PM EDT
Solutions Circle: FDA Expectations for Digital Health Tools in Decentralized Clinical Trials
Thursday, October 5, 2023
11:25 AM – 11:55 AM EDT